RTX Q3 2026 Earnings Analysis
RTX delivered strong Q3 results with $25B sales (+12% organic) and record $340B backlog; full-year 2026 guidance raised across sales, EPS, and free cash flow.
Key Metrics
Puntos clave
- Q3 organic sales +12% across all segments; record backlog $340B (+36% YoY) driven by munitions conversions
- Raytheon booked ~$59B defense awards including $23B Tomahawk and $14B AMRAAM converted to multiyear contracts
- Raising FY26 guidance: sales to $97.0-97.5B, EPS to $7.65-7.75, FCF to $9.0-9.2B reflecting strong execution
Escuchar en
Disponible en
Transcript
// Full episode scriptWelcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.
And I'm Jordan. Today we're diving into RTX's third quarter 2026 results, and Alex, this one's got some big numbers.
It really does. But before we jump in, quick note — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.
Important stuff. Okay, let's get into it.
So RTX — the parent company of Raytheon, Pratt & Whitney, and Collins Aerospace — reported adjusted sales of $25 billion for Q3, up 12% organically. That's growth across all three segments, which is pretty rare to see all firing at once.
And the EPS number really jumps out — $2.26, up 33% year-over-year. But here's the asterisk: $0.25 of that came from something called IEEPA cost recovery. That's basically tariff-related cost reimbursement, not pure operational performance.
Right, so strip that out and you're still looking at really solid underlying growth — about 43 cents of that EPS gain came from actual segment operating profit improvement.
And free cash flow was strong too — $2.1 billion for the quarter. The company also raised full-year guidance across the board. New sales range is $97 to $97.5 billion, up from $95-96 billion. EPS guidance jumped to $7.65-$7.75, up from $7.10-$7.25.
Now let's talk backlog, because this is the headline for me. $340 billion — up 36% year-over-year, 18% just sequentially. That's a massive number.
It's driven largely by defense. Raytheon booked almost $59 billion in awards this quarter alone — a book-to-bill ratio of 4.57 times. The big drivers were converting framework agreements into actual multi-year production contracts — about $23 billion for Tomahawk missiles and over $14 billion for AMRAAM.
And they followed that up with multi-year contracts for SM-6 and SM-3 IIA missiles too. Management described this whole munitions push as converting nearly a decade's worth of demand visibility into firm contracts.
Which is great, but it comes with execution risk. CEO Christopher Calio talked about needing to ramp production 2x to 4x on some of these munitions. That means supply chain expansion, new suppliers — they added 150 new suppliers at Raytheon in 2025 alone — and working through bottlenecks like castings and solid rocket motors.
Yeah, one analyst actually asked about printed circuit boards and capacitors being hard to source because of the AI data center buildout competing for the same components. Calio acknowledged it's a real constraint they're actively managing with the Department of Defense.
On the commercial side, let's talk Pratt & Whitney and the GTF engine story, because that's been the long-running saga for RTX.
Right, the GTF — Geared Turbofan — has had durability issues for years that required extra maintenance checks. The good news this quarter: MRO output on the PW1100 engine was up 37% year-over-year, and critically, the GTF Advantage — the next-gen version with double the time-on-wing performance — just entered service with United Airlines.
That's a real milestone. And there's also a retrofit kit called Hot Section Plus coming next year that'll bring most of those durability benefits to the existing fleet without needing a whole new engine.
Commercial aftermarket overall grew 16% organically, which is impressive given that global air traffic — RPKs — actually declined slightly. CFO Neil Mitchill noted about 60% of the Pratt Canada business jet fleet hasn't even had its first shop visit yet, so there's a long runway there.
Collins Aerospace also had a strong quarter — margins expanded 560 basis points, partly from IEEPA recovery, but also from real structural cost cuts — consolidating operations, cutting overhead, reducing indirect headcount while still growing sales double digits.
One thing I thought was notable in the Q&A — an analyst asked about cash flow sustainability given all these new munitions contracts. Management said the funding structure on those contracts is designed to be roughly cash-neutral, so it shouldn't drain free cash flow even as they ramp up capacity investment.
And there was a good exchange about airline demand resilience too. With fuel costs pressuring some airlines, an analyst asked if RTX was seeing any pullback. Calio's answer was essentially: not yet — demand has stayed resilient, retirements are in line with expectations, and the structural tailwinds like out-of-warranty flight hours and fleet growth are still intact.
So what does this all mean for investors going forward?
I think the story is pretty clear — RTX has visibility into years of growth thanks to this record backlog, both from defense munitions demand and the commercial aftermarket recovery. The risk is execution — can they actually scale production fast enough, secure the supply chain, and avoid the bottlenecks they flagged today?
And worth watching: how much of this quarter's margin strength was IEEPA-related versus structural. That's a distinction that'll matter a lot in 2027 when some of these one-time tailwinds fade.
Definitely something to track. And speaking of which — everything discussed is AI-generated analysis for educational purposes. Past performance doesn't guarantee future results. Please do your own due diligence.
Well said. RTX management will be back in January with their full 2027 outlook, so we'll have a much clearer picture of how this munitions ramp and GTF recovery are tracking.
Lots to watch — supply chain execution, margin trajectory at Pratt and Collins, and whether that backlog keeps converting into real revenue.
That's all for this episode of Beta Finch.
Thanks for listening — we'll catch you next time.